a clinical-stage biotechnology company focused on treating rare diseases, today announced that the U.S. Food and Drug Administration (FDA) has granted Orphan Drug Designation to EXG-34217 ...
Ridofranz /Getty Image As with most other professions, individuals in the employee benefits field often seek to obtain various designations to demonstrate their level of knowledge of retirement ...
11 小时
Sourcing Journal on MSNBankruptcy Court Shoots Down Teamsters’ Claims that Yellow Violated WARN ActThe trucking company was found to be not liable for failing to provide 60 days’ notice to union employees when it ceased ...
Innate Pharma SA (Euronext Paris: IPH; Nasdaq: IPHA) (“Innate” or the “Company”) today announced that the U.S. Food and Drug Administration (FDA) has ...
20 小时on MSN
U.S. Army veteran Ramiro Céspedes speaks out after his father was killed by a cartel-linked improvised explosive device (IED) ...
A Breakthrough Therapy Designation by the FDA is intended to accelerate the development and regulatory review in the U.S. of drugs that are intended to treat a serious condition and that have ...
The designation reflects the FDA’s determination that the device is reasonably expected to provide for more effective treatment or diagnosis of life-threatening or irreversibly debilitating ...
(RTTNews) - BioRestorative Therapies, Inc. (BRTX) announced that the FDA has granted Fast Track designation to its lead candidate, BRTX-100, for the treatment of chronic lumbar disc disease or cLDD.
LITTLE ROCK, Ark. (KATV) — Little Rock's own, LISA Academy North High School, made history by becoming the first school in Arkansas to earn the Character School Designation, which recognizes ...
A number of our courses can prepare you to either earn a professional designation or help you maintain it. For the most up-to-date information, please consult the organization that administers the ...
Innate Pharma shares were up 16% to $2.25 after the company said the Food and Drug Administration has granted Breakthrough Therapy Designation to lacutamab for the treatment of adult patients with ...
“This is the second such designation for our ACR-368 OncoSignature assay and represents yet another powerful validation of our generative AI-driven AP3 platform. The enrollment and dosing ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果